In thyroid, prostate, colon, and breast cancer, Wnt5A is suggested to have a tumor-suppressor role wherein reconstitution of Wnt5A impairs tumor metastasis by targeting cell motility and, therefore, is associated with a higher disease-free survival [176]. Here, WNT5A is linked to breast carcinoma.